Pawłowska, A.; Skiba, W.; Suszczyk, D.; Kuryło, W.; Jakubowicz-Gil, J.; Paduch, R.; Wertel, I.
The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients. Cancers 2022, 14, 5757.
https://doi.org/10.3390/cancers14235757
AMA Style
Pawłowska A, Skiba W, Suszczyk D, Kuryło W, Jakubowicz-Gil J, Paduch R, Wertel I.
The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients. Cancers. 2022; 14(23):5757.
https://doi.org/10.3390/cancers14235757
Chicago/Turabian Style
Pawłowska, Anna, Wiktoria Skiba, Dorota Suszczyk, Weronika Kuryło, Joanna Jakubowicz-Gil, Roman Paduch, and Iwona Wertel.
2022. "The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients" Cancers 14, no. 23: 5757.
https://doi.org/10.3390/cancers14235757
APA Style
Pawłowska, A., Skiba, W., Suszczyk, D., Kuryło, W., Jakubowicz-Gil, J., Paduch, R., & Wertel, I.
(2022). The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients. Cancers, 14(23), 5757.
https://doi.org/10.3390/cancers14235757